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Mycoplasma pneumoniae is one of the most
common etiologic agents of atypical pneumonia. Although the majority of the clinical syndromes caused
by this organism present as asymptomatic infection or
upper respiratory tract infection, about 3% of the patients infected admit signs and symptoms of pneumonia (1). Although the exact mechanism of the extrapulmonary complications seen during the course of
mycoplasma infections is not well understood, immune
complex and autoantibody production are blamed for
this entity. Autoantibody production is probably due to
the antigenic mimicry between the host and the microorganism or antigenic variation of the host cells occuring during the infectious process. Antinuclar antibody (ANA) is one of the autoantibodies which is
occasionally detected in sera of patients with mycoplasmal pneumonia (2,3).
We searched for the presence of ANA in a total of
22 serum samples collected from 11 patients who
were diagnosed to have pneumonia caused by Mycoplasma pneumoniae depending on the culture results
of protected brush specimens obtained during the
acute phase of the disease. Two serum samples were
collected from each patient, one in the acute and another in the convalescent phase of the disease, with
an interval of 14 days. ANA detection was done by
using indirect flourescent antibody technique (4). All
but one of the samples gave negative result. The ser-

um sample which was found to be positive for ANA at
a titer of 1/80 dilution showed homogenous staining
pattern and belonged to a 44 years old previously
healthy female patient who presented with fever,
cough, mucoid sputum production, myalgia, arthralgia,
abdominal pain and constipation. She had no history
of any underlying disease or medication that could explain ANA positivity. One physical examination, nothing
was remarkable except crepitation at right lower thoracic area. Chest radiographic findings revealed infiltration at lower lobe of the right lung. Cultivation
of protected brush specimen yielded Mycoplasma pneumoniae. The patient had clinical and radiological cure
after appropriate antimicrobial therapy was administered. No extrapulmonary complications were observed. The second serum sample of the same patient
was found to be negative for ANA. Flourescent antibody tests of both samples of the patient were repeated three times and the results did not change. Occasional detection of ANA in sera of patients with
mycoplasmal pneumonia is a known entity. The reason
why the second serum sample of the patient in our
study was negative for ANA may be the reversible polyclonal B cell activation. We emphasize that ANA might
be detected in serum samples of patients with Mycoplasma pneumoniae infections. In cases for whom
the finding of a positive ANA value is unexpected, the
probability of a recent Mycoplasma infection should be
kept in mind.
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